Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/134680
Title: A NOVEL FLOW SYSTEM UTILIZING AN EXPLANTED PORCINE HEART TO DETERMINE THE EFFICACY OF CAVAL VALVE IMPLANTATION
Authors: KARTHIC ANBALAKAN
Keywords: Tricuspid Valve, Regurgitation, Caval Valve Implantation, Heterotopic Implantation, Proximal Isovelocity Surface Area, In vitro Flow System
Issue Date: 18-Aug-2016
Source: KARTHIC ANBALAKAN (2016-08-18). A NOVEL FLOW SYSTEM UTILIZING AN EXPLANTED PORCINE HEART TO DETERMINE THE EFFICACY OF CAVAL VALVE IMPLANTATION. ScholarBank@NUS Repository.
Abstract: Tricuspid regurgitation is one of the often neglected pathologies which can occur secondary to left sided heart disease. The current treatment methods are open surgical procedures which carry a high operative mortality. Therefore, TR is often left untreated in patients where the risks outweigh the benefits. To exacerbate this further, TR was found to be progressive and could potentially worsen significantly within 5 years. In this study, the efficacy of a new percutaneous transcatheter technique, known as Caval Valve Implantation (CAVI), was investigated; through the development of an in-vitro flow system which utilized an explanted porcine heart. From the results, the cardiac output was found to be 2.22 times greater after CAVI and the Jugular Venous Pressure waveform was restored. Moreover, 2D-pulse-wave-color Doppler echocardiography reflected a 2.42 fold decrease in the Effective-Regurgitant-Orifice-Area after CAVI. These results support the efficacy of CAVI and its potential to treat the symptoms of TR.
URI: http://scholarbank.nus.edu.sg/handle/10635/134680
Appears in Collections:Master's Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Karthic.pdf3.35 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

33
checked on Jan 21, 2018

Download(s)

37
checked on Jan 21, 2018

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.